{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:26:50Z","timestamp":1786789610163,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Rossy Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03068-5","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:57:06Z","timestamp":1786787826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct alpha-synuclein seeding in post-mortem skin of Lewy body disease and multiple system atrophy"],"prefix":"10.1007","volume":"152","author":[{"given":"Ain","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarig","family":"Abkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-6321","authenticated-orcid":false,"given":"Ivan","family":"Martinez-Valbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"3068_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","volume":"18","author":"G Bellomo","year":"2023","unstructured":"Bellomo G, Paciotti S, Concha-Marambio L, Rizzo D, Wojda\u019aa AL, Chiasserini D et al (2023) Cerebrospinal fluid lipoproteins inhibit alpha-synuclein aggregation by interacting with oligomeric species in seed amplification assays. Mol Neurodegener 18:20. https:\/\/doi.org\/10.1186\/s13024-023-00613-8","journal-title":"Mol Neurodegener"},{"key":"3068_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-025-02973-5","volume":"151","author":"M Gerasimenko","year":"2026","unstructured":"Gerasimenko M, Yi H, Gilliland T, Chen Y, Wang Z, Zou WQ (2026) Biochemical signatures of skin alpha-synuclein in synucleinopathies revealed by RT-QuIC assay end-product analysis. Acta Neuropathol 151:3. https:\/\/doi.org\/10.1007\/s00401-025-02973-5","journal-title":"Acta Neuropathol"},{"key":"3068_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41591-026-04398-3","volume":"32","author":"I Martinez-Valbuena","year":"2026","unstructured":"Martinez-Valbuena I, Emamikhah M, Olszewska DA, Weber SK, Schnell S, Fereshtehnejad SM et al (2026) A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism. Nat Med 32:2073\u20132082. https:\/\/doi.org\/10.1038\/s41591-026-04398-3","journal-title":"Nat Med"},{"key":"3068_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","volume":"144","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Swinkin E, Santamaria E, Fernandez-Irigoyen J, Sackmann V, Kim A et al (2022) Alpha-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders. Acta Neuropathol 144:167\u2013185. https:\/\/doi.org\/10.1007\/s00401-022-02453-0","journal-title":"Acta Neuropathol"},{"key":"3068_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","volume":"11","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Visanji NP, Kim A, Lau HHC, So RWL, Alshimemeri S et al (2022) Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy. Transl Neurodegener 11:7. https:\/\/doi.org\/10.1186\/s40035-022-00283-4","journal-title":"Transl Neurodegener"},{"key":"3068_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/mds.28912","volume":"37","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena I, Visanji NP, Olszewska DA, Sousa M, Bhakta P, Vasilevskaya A et al (2022) Combining skin alpha-synuclein real-time quaking-induced conversion and circulating neurofilament light chain to distinguish multiple system atrophy and Parkinson\u2019s disease. Mov Disord 37:648\u2013650. https:\/\/doi.org\/10.1002\/mds.28912","journal-title":"Mov Disord"},{"key":"3068_CR7","doi-asserted-by":"publisher","first-page":"24999","DOI":"10.1021\/acsomega.3c01606","volume":"8","author":"HZ Mou","year":"2023","unstructured":"Mou HZ, Zhao CL, Song J, Xing L, Chen HY, Xu JJ (2023) Ambient temperature affects protein self-assembly by interfering with the interfacial aggregation behavior. ACS Omega 8:24999\u201325008. https:\/\/doi.org\/10.1021\/acsomega.3c01606","journal-title":"ACS Omega"},{"key":"3068_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating alpha-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03068-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:57:06Z","timestamp":1786787826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03068-5","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AEL has served as an advisor for\u00a0AbbVie, Amylyx, Biogen, Biohaven, BlueRock, EG427, Ferrer, Janssen, and Ventyx; received honoraria from\u00a0AbbVie; received grants from Canadian Institutes of Health Research, Edmond J Safra Philanthropic Foundation, Krembil Brain Institute, Michael J. Fox Foundation, Parkinson Foundation, Parkinson Canada, and The Rossy Foundation; has served as an expert witness in litigation related to paraquat and Parkinson\u2019s disease, received publishing royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. M.C.T. receives funding from the NIH, the Weston Brain Foundation, the Tanenbaum Institute for Research in Science of Sport, the Canadian Institutes of Health Research, and in-kind funding from Roche; she has served as an advisor to Eisai, Lilly, and Novo Nordisk, and she conducts clinical trials for Biogen, Anavex, Janssen, Novo Nordisk, Bristol Myers Squibb, Aribio, Green Valley, UCB, and Passage Bio. IMV has a pending patent for Diagnostic assays for movement disorders (18\/537,455) and receives research funding from the Rossy Family Foundation, the Blidner family, Ajay Virmani, and the Michael J. Fox Foundation. GGK reports personal fees from Parexel, Ferrer, Treventis, and Mitsubishi-Tanabe; funding from Rossy Family Foundation, from Edmond Safra Foundation, grants from Krembil Foundation, MSA Coalition, MJ Fox Foundation, Parkinson Canada, NIH, Canada Foundation for Innovation, and Ontario Research Fund outside the submitted work; in addition, GGK has a shared patent for 5G4 Synuclein antibody and a pending patent for Diagnostic assays for movement disorders (18\/537,455), and received royalties from Wiley, Cambridge, Taylor and Francis, and Elsevier publishers. AK, TA, ME, and XX have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19"}}